What is the share price of Fermenta Biotech Ltd (FERMENTA) today?
The share price of FERMENTA as on 18th September 2025 is ₹347. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Fermenta Biotech Ltd (FERMENTA) share?
The past returns of Fermenta Biotech Ltd (FERMENTA) share are- Past 1 week: -2.33%
- Past 1 month: -3.05%
- Past 3 months: 5.04%
- Past 6 months: 40.50%
- Past 1 year: 20.16%
- Past 3 years: 60.14%
- Past 5 years: -4.14%
What are the peers or stocks similar to Fermenta Biotech Ltd (FERMENTA)?
The peers or stocks similar to Fermenta Biotech Ltd (FERMENTA) include:What is the dividend yield % of Fermenta Biotech Ltd (FERMENTA) share?
The current dividend yield of Fermenta Biotech Ltd (FERMENTA) is 0.72.What is the market cap of Fermenta Biotech Ltd (FERMENTA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Fermenta Biotech Ltd (FERMENTA) is ₹1024.12 Cr as of 18th September 2025.What is the 52 week high and low of Fermenta Biotech Ltd (FERMENTA) share?
The 52-week high of Fermenta Biotech Ltd (FERMENTA) is ₹449 and the 52-week low is ₹219.What is the PE and PB ratio of Fermenta Biotech Ltd (FERMENTA) stock?
The P/E (price-to-earnings) ratio of Fermenta Biotech Ltd (FERMENTA) is 13.32. The P/B (price-to-book) ratio is 2.86.Which sector does Fermenta Biotech Ltd (FERMENTA) belong to?
Fermenta Biotech Ltd (FERMENTA) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Fermenta Biotech Ltd (FERMENTA) shares?
You can directly buy Fermenta Biotech Ltd (FERMENTA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Fermenta Biotech Ltd
FERMENTA Share Price
FERMENTA Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
AvgCan be considered moderately valued vs the market
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
FERMENTA Performance & Key Metrics
FERMENTA Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
9.80 | 2.86 | 0.72% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
37.23 | 5.88 | 0.58% |
FERMENTA Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
FERMENTA Company Profile
Fermenta Biotech Ltd manufactures vitamin D and active pharmaceutical ingredients while providing environmental solutions and renting properties, serving various industries including pharmaceuticals and nutrition.
FERMENTA Forecast
FERMENTA Forecasts
FERMENTA
FERMENTA
Income
Balance Sheet
Cash Flow
FERMENTA Income Statement
FERMENTA Income Statement
Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 166.81 | 311.01 | 415.82 | 304.03 | 385.54 | 406.66 | 358.54 | 347.47 | 481.30 | 545.38 | ||||||||||
Raw Materials | 82.10 | 85.19 | 105.08 | 106.11 | 163.12 | 146.88 | 131.04 | 104.02 | 178.56 | 390.38 | ||||||||||
Power & Fuel Cost | 9.75 | 10.86 | 13.88 | 12.74 | 14.23 | 20.35 | 18.24 | 19.78 | 27.23 | |||||||||||
Employee Cost | 30.84 | 39.83 | 53.18 | 50.03 | 58.22 | 62.97 | 58.00 | 58.55 | 65.10 | |||||||||||
Selling & Administrative Expenses | 18.66 | 42.70 | 53.10 | 47.57 | 41.03 | 46.13 | 47.53 | 40.65 | 48.17 | |||||||||||
Operating & Other expenses | 10.71 | 30.46 | 28.76 | 9.07 | 17.99 | 59.83 | 105.41 | 92.19 | 39.92 | |||||||||||
EBITDA | 14.75 | 101.97 | 161.82 | 78.51 | 90.95 | 70.50 | -1.68 | 32.28 | 122.32 | 155.00 | ||||||||||
Depreciation/Amortization | 10.31 | 12.36 | 11.89 | 15.00 | 20.31 | 25.56 | 28.25 | 24.72 | 24.22 | 23.90 | ||||||||||
PBIT | 4.44 | 89.61 | 149.93 | 63.51 | 70.64 | 44.94 | -29.93 | 7.56 | 98.10 | 131.10 | ||||||||||
Interest & Other Items | 9.96 | 13.63 | 21.23 | 20.09 | 19.00 | 17.98 | 21.37 | 17.43 | 14.89 | 13.87 | ||||||||||
PBT | -5.52 | 75.98 | 128.70 | 43.42 | 51.64 | 26.96 | -51.30 | -9.87 | 83.21 | 117.23 | ||||||||||
Taxes & Other Items | 5.89 | 42.25 | 11.26 | -16.11 | 6.12 | 11.50 | -0.23 | 13.19 | 6.34 | 12.71 | ||||||||||
Net Income | -11.41 | 33.73 | 117.44 | 59.53 | 45.52 | 15.46 | -51.07 | -23.06 | 76.87 | 104.52 | ||||||||||
EPS | -4.15 | 12.26 | 42.68 | 21.12 | 15.78 | 5.31 | -17.35 | -7.84 | 26.12 | 35.51 | ||||||||||
DPS | 0.21 | 0.21 | 0.42 | 5.00 | 2.50 | 1.25 | 1.25 | 1.25 | 2.50 | 1.25 | ||||||||||
Payout ratio | — | 0.02 | 0.01 | 0.24 | 0.16 | 0.24 | — | — | 0.10 | 0.04 |
FERMENTA Company Updates
FERMENTA Stock Peers
FERMENTA Past Performance & Peer Comparison
FERMENTA Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Fermenta Biotech Ltd | 13.32 | 2.86 | 0.72% |
Sun Pharmaceutical Industries Ltd | 35.57 | 5.36 | 0.99% |
Cipla Ltd | 23.89 | 4.03 | 1.03% |
Torrent Pharmaceuticals Ltd | 62.83 | 15.82 | 0.90% |
FERMENTA Stock Price Comparison
Compare FERMENTA with any stock or ETFFERMENTA Holdings
FERMENTA Shareholdings
FERMENTA Promoter Holdings Trend
FERMENTA Promoter Holdings Trend
In last 6 months, promoter holding in the company has increased by 2.02%
Pledged promoter holdings is insignificant
FERMENTA Institutional Holdings Trend
FERMENTA Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
FERMENTA Shareholding Pattern
FERMENTA Shareholding Pattern
FERMENTA Shareholding History
FERMENTA Shareholding History
smallcases containing FERMENTA stock
smallcases containing FERMENTA stock
Looks like this stock is not in any smallcase yet.
FERMENTA Events
FERMENTA Events
FERMENTA Dividend Trend
Current dividend yield is 0.72%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹7.18 every year
Dividends
Corp. Actions
Announcements
Legal Orders
FERMENTA Dividend Trend
Current dividend yield is 0.72%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹7.18 every year
FERMENTA Upcoming Dividends
FERMENTA Upcoming Dividends
No upcoming dividends are available
FERMENTA Past Dividends
FERMENTA Past Dividends
Cash Dividend
Ex DateEx DateAug 6, 2025
Dividend/Share
₹2.50
Ex DateEx Date
Aug 6, 2025
Cash Dividend
Ex DateEx DateAug 6, 2024
Dividend/Share
₹1.25
Ex DateEx Date
Aug 6, 2024
Cash Dividend
Ex DateEx DateSep 22, 2023
Dividend/Share
₹1.25
Ex DateEx Date
Sep 22, 2023
Cash Dividend
Ex DateEx DateAug 4, 2022
Dividend/Share
₹1.25
Ex DateEx Date
Aug 4, 2022
Cash Dividend
Ex DateEx DateAug 25, 2021
Dividend/Share
₹2.50
Ex DateEx Date
Aug 25, 2021
FERMENTA Stock News & Opinions
FERMENTA Stock News & Opinions
Fermenta Biotech announced that the Indian Patent Office has formally granted a patent for its invention of a plant-based Vitamin D3. Fermenta's newly granted patent safeguards its proprietary process for producing plant based Vitamin D3, marking a significant advancement in its innovation pipeline and reinforcing its leadership in the global Vitamin D3 domain. This market-leading vegan solution responds to the accelerating global demand for ethically sourced, sustainable nutrition and positions Fermenta at the forefront of the plant-based nutrition revolution. By enabling the production of completely vegan and vegetarian-friendly Vitamin D3, the invention captures emerging opportunities across nutraceutical and food fortification sectors, where sustainable, plant-derived ingredients command premiums and growing market share. Prashant Nagre, Managing Director of Fermenta, said: 'The grant of this patent is a proud milestone in our journey of innovation. It reflects our dedication to addressing evolving consumer needs with environmentally conscious solutions. Plant-based Vitamin D3 represents the future of nutrition, and this patent reinforces our ability to deliver differentiated offerings that create long-lasting impact for both our partners and society at large. It also strengthens India's role as a hub for pioneering industrial innovation, showcasing how local science can contribute to global wellness.' Powered by Capital Market - Live
Net profit of Fermenta Biotech reported to Rs 21.83 crore in the quarter ended June 2025 as against net loss of Rs 5.82 crore during the previous quarter ended June 2024. Sales rose 74.40% to Rs 136.26 crore in the quarter ended June 2025 as against Rs 78.13 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales136.2678.13 74 OPM %20.721.02 - PBDT33.900.19 17742 PBT28.09-5.93 LP NP21.83-5.82 LP Powered by Capital Market - Live
Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live
Fermenta Biotech announced that the Annual General Meeting(AGM) of the company will be held on 12 August 2025.Powered by Capital Market - Live
Fermenta Biotech announced that the Board of Directors of the Company at its meeting held on 28 May 2025, inter alia, have recommended the final dividend of Rs 2.5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.Powered by Capital Market - Live
Net profit of Fermenta Biotech reported to Rs 34.39 crore in the quarter ended March 2025 as against net loss of Rs 6.94 crore during the previous quarter ended March 2024. Sales rose 43.67% to Rs 139.85 crore in the quarter ended March 2025 as against Rs 97.34 crore during the previous quarter ended March 2024. For the full year,net profit reported to Rs 76.86 crore in the year ended March 2025 as against net loss of Rs 23.06 crore during the previous year ended March 2024. Sales rose 39.87% to Rs 469.48 crore in the year ended March 2025 as against Rs 335.66 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales139.8597.34 44 469.48335.66 40 OPM %26.425.53 -23.398.20 - PBDT37.857.37 414 107.4322.28 382 PBT31.980.91 3414 83.21-2.44 LP NP34.39-6.94 LP 76.86-23.06 LP Powered by Capital Market - Live
Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live
Net profit of Fermenta Biotech rose 274.72% to Rs 36.91 crore in the quarter ended December 2024 as against Rs 9.85 crore during the previous quarter ended December 2023. Sales rose 58.10% to Rs 156.47 crore in the quarter ended December 2024 as against Rs 98.97 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales156.4798.97 58 OPM %34.0425.38 - PBDT51.4222.46 129 PBT45.3416.07 182 NP36.919.85 275 Powered by Capital Market - Live
Net profit of Fermenta Biotech rose 199.15% to Rs 35.00 crore in the quarter ended December 2024 as against Rs 11.70 crore during the previous quarter ended December 2023. Sales rose 63.68% to Rs 146.25 crore in the quarter ended December 2024 as against Rs 89.35 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales146.2589.35 64 OPM %34.2829.65 - PBDT48.2723.91 102 PBT42.4517.78 139 NP35.0011.70 199 Powered by Capital Market - Live
Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 11 February 2025.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 9.62%, vs industry avg of 9.99%
Over the last 5 years, market share decreased from 0.12% to 0.11%
Over the last 5 years, net income has grown at a yearly rate of 5.25%, vs industry avg of 20.01%